NASDAQ: KRMDKoru Medical Systems Inc Stock
$4.00+0.00 (+0%)
Updated Jun 12, 2026
KRMD Price
$4.00
Fair Value Price
N/A
Market Cap
$183.73M
52 Week Low
$2.91
52 Week High
$6.61
P/E
-80x
P/B
10.86x
P/S
4.63x
PEG
N/A
Dividend Yield
N/A
Revenue
$43.26M
Earnings
-$2.28M
Gross Margin
61.9%
Operating Margin
-5.22%
Profit Margin
-5.3%
Debt to Equity
0.69
Operating Cash Flow
$715k
Beta
0.95
Next Earnings
Aug 5, 2026
Ex-Dividend
N/A
Next Dividend
N/A
KRMD Overview
KORU Medical Systems, Inc. is dedicated to the development, manufacturing, and commercialization of mobile medical devices, primarily serving the ambulatory infusion market across both the United States and international territories. The company's primary offerings revolve around mechanical infusion solutions, notably their FREEDOM infusion systems. These comprehensive systems encompass components such as the FREEDOM60 and FreedomEdge syringe drivers, alongside specialized HIgH-Flo subcutaneous safety needle sets and precision flow rate tubing. Beyond their product range, KORU Medical also supplies educational content and training materials to healthcare professionals, patients, and patient advocates. The distribution of their products is managed through a combination of direct sales efforts, partnerships with medical device distributors, and online channels. Established in 1980, the firm's corporate headquarters are situated in Chester, New York.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine KRMD's potential to beat the market
CHold
- Stocks with a Zen Rating of Hold (C) had an average return of +7.53% per year. Learn More
Zen Rating Component Grades
C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Medical
Industry Rating
B
KRMD
Ranked#18 of 42
Ranked#18 of 42
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $9.14 | A | |
| $142.20 | B | |
| $15.08 | B |
Be the first to know about important KRMD news, forecast changes, insider trades & much more!
KRMD News
Overview
Due Diligence Score
–
Industry Average (30)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how KRMD scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
KRMD is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
KRMD is poor value based on its book value relative to its share price (10.86x), compared to the US Medical Instruments & Supplies industry average (3.19x)
P/B vs Industry Valuation
KRMD is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more KRMD due diligence checks available for Premium users.
Valuation
KRMD fair value
Fair Value of KRMD stock based on Discounted Cash Flow (DCF)
Price
$4.00
Fair Value
-$3.95
Undervalued by
201.39%
KRMD is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
KRMD price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-80x
Industry
42.82x
Market
14.15x
KRMD price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
10.86x
Industry
3.19x
KRMD is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation
KRMD's financial health
Profit margin
Revenue
$11.8M
Net Income
-$807.1k
Profit Margin
-6.9%
KRMD's Earnings (EBIT) of -$2.26M... subscribe to Premium to read more.
Interest Coverage Financials
KRMD's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$28.6M
Liabilities
$11.7M
Debt to equity
0.69
KRMD's short-term assets ($20.59M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
KRMD's short-term assets ($20.59M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
KRMD's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
KRMD's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$14.7k
Investing
-$89.9k
Financing
-$29.2k
KRMD's operating cash flow ($714.54k)... subscribe to Premium to read more.
Debt Coverage Financials
KRMD vs Medical Stocks
Koru Medical Systems Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.